Alzamend Neuro Inc. (ALZN)
NASDAQ: ALZN
· Real-Time Price · USD
2.38
-0.05 (-2.06%)
At close: Aug 15, 2025, 3:59 PM
2.41
1.26%
After-hours: Aug 15, 2025, 07:41 PM EDT
Alzamend Neuro Income Statement
Financials in USD. Fiscal
year is
May - April.
Fiscal Year | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Apr 30, 2025 | Jan 31, 2025 | Oct 31, 2024 | Jul 31, 2024 | Apr 30, 2024 | Jan 31, 2024 | Oct 31, 2023 | Jul 31, 2023 | Apr 30, 2023 | Jan 31, 2023 | Oct 31, 2022 | Jul 31, 2022 | Apr 30, 2022 | Jan 31, 2022 | Oct 31, 2021 | Jul 31, 2021 | Apr 30, 2021 | Jan 31, 2021 | Oct 31, 2020 | Jul 31, 2020 |
Revenue | n/a | 76.11K | 76.11K | 76.11K | 76.11K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 50.74K | 50.74K | 50.74K | 50.74K | 50.74K | 43.38K | 36.02K | 28.65K | 23.07K | 17.74K | 12.42K | 7.1K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | -50.74K | -50.74K | -50.74K | -50.74K | -50.74K | -43.38K | -30.69K | -23.33K | -17.74K | -12.42K | -12.42K | -7.1K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Income | -4.5M | -4.21M | -5.83M | -7.37M | -9.94M | -12.39M | -15.16M | -15.36M | -14.87M | -15.44M | -12.57M | -13.05M | -12.32M | -9.67M | -8.23M | -5.94M | -4.95M | -4.99M | -5.15M | -4.8M |
Interest Income | n/a | n/a | n/a | n/a | n/a | 0.52 | 0.52 | 4.11 | 4.11 | 3.59 | 3.59 | n/a | n/a | n/a | n/a | n/a | 1.71K | 4.2K | 6.74K | 11.19K |
Pretax Income | -4.51M | -4.23M | -5.85M | -7.39M | -9.95M | -12.4M | -15.17M | -15.37M | -14.88M | -15.44M | -12.59M | -13.08M | -12.36M | -9.75M | -8.3M | -6.05M | -5.05M | -5.05M | -5.2M | -4.79M |
Net Income | -4.51M | -4.23M | -5.85M | -7.39M | -9.95M | -12.4M | -15.17M | -15.37M | -14.88M | -15.45M | -12.59M | -13.08M | -12.36M | -9.75M | -8.3M | -6.05M | -5.05M | -5.05M | -5.2M | -4.79M |
Selling & General & Admin | 3.08M | 3.06M | 3.21M | 3.07M | 3.47M | 4.46M | 6.26M | 6.93M | 7.42M | 7.98M | 7.13M | 7.39M | 7.12M | 5.83M | 5.03M | 4.02M | 3.64M | 3.73M | 3.7M | 3.62M |
Research & Development | 1.41M | 1.15M | 2.61M | 4.3M | 6.46M | 7.92M | 8.9M | 8.44M | 7.45M | 7.46M | 5.44M | 5.66M | 5.2M | 3.83M | 3.19M | 1.92M | 1.31M | 1.26M | 1.45M | 1.18M |
Other Expenses | -503 | -503 | -88 | 0.00 | 0.00 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 4.5M | 4.19M | 5.8M | 7.35M | 9.91M | 12.38M | 15.16M | 15.36M | 14.87M | 15.44M | 12.57M | 13.05M | 12.32M | 9.67M | 8.23M | 5.94M | 4.95M | 4.99M | 5.15M | 4.8M |
Interest Expense | 18.03K | 18.98K | 19.45K | 20.27K | 10.1K | 9.15K | 8.73K | 8K | 7.7K | 7.78K | 22.02K | 34.43K | 46.52K | 82.78K | 132.12K | 172.28K | 158.8K | 121.94K | 56.3K | 151.00 |
Selling & Marketing Expenses | 307.3K | 304K | 291.31K | -12.69K | 234.65K | 481.98K | 742K | 989.34K | 742K | 494.67K | 247.33K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 4.5M | 4.21M | 5.83M | 7.37M | 9.94M | 12.39M | 15.16M | 15.36M | 14.87M | 15.44M | 12.57M | 13.05M | 12.32M | 9.67M | 8.23M | 5.94M | 4.95M | 4.99M | 5.15M | 4.8M |
Income Tax Expense | n/a | -2 | -7 | -7 | -30.6K | -37.78K | -37.77K | -34.19K | -2.06K | 1.72K | 1.72K | -1.87K | -3.4K | n/a | n/a | n/a | n/a | n/a | 2.54K | 6.99K |
Shares Outstanding (Basic) | 778.73K | 5.52M | 3.53M | 777.82K | 3.44M | 705.43K | 3.28M | 3.28M | 3.23M | 3.27M | 3.25M | 3.25M | 2.93M | 3.13M | 3.12M | 2.77M | 2.46M | 2.4M | 2.4M | 2.4M |
Shares Outstanding (Diluted) | 778.73K | 5.52M | 3.53M | 777.82K | 3.44M | 705.43K | 3.28M | 3.28M | 3.23M | 3.28M | 3.25M | 3.25M | 2.93M | 3.14M | 3.12M | 2.77M | 2.46M | 2.41M | 2.41M | 2.41M |
EPS (Basic) | -4.06 | -3.08 | -6.66 | -10.69 | -14.82 | -18.7 | -23.23 | -23.6 | -22.72 | -24.2 | -20.4 | -21.38 | -17.72 | -13.67 | -11.04 | -7.52 | -8.88 | -8.95 | -9.75 | -9.48 |
EPS (Diluted) | -4.06 | -3.08 | -6.66 | -10.69 | -14.82 | -18.7 | -23.23 | -23.6 | -22.72 | -24.2 | -20.4 | -21.6 | -17.94 | -13.89 | -11.26 | -7.52 | -8.88 | -8.95 | -9.75 | -9.48 |
EBITDA | -4.45M | -4.16M | -5.78M | -7.32M | -9.89M | -12.35M | -15.12M | -15.33M | -14.85M | -15.42M | -12.56M | -13.04M | -12.32M | -9.67M | -8.16M | -5.88M | -4.89M | -4.94M | -3.88M | -2.58M |
EBIT | -4.5M | -4.21M | -5.83M | -7.37M | -9.94M | -12.39M | -15.16M | -15.36M | -14.87M | -15.43M | -12.57M | -13.05M | -12.32M | -9.67M | -8.16M | -5.88M | -4.89M | -4.94M | -5.16M | -4.81M |
Depreciation & Amortization | 50.74K | 50.74K | 50.74K | 50.74K | 50.74K | 43.38K | 36.02K | 28.65K | 23.07K | 18.63K | 1.14M | 2.42M | 4.72M | 5.94M | 5.92M | 5.94M | 4.95M | 4.99M | 5.15M | 4.8M |